Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

Invitation to Surgical Science’s Capital Markets Day 2025

Surgical Science Sweden

Surgical Science invites institutional investors, analysts and media representatives to the company’s Capital Markets Day on Monday, December 8, 2025 from 14:00 to 16:30 CET.

The Capital Markets Day will be conducted as a hybrid event, with the opportunity to participate on site at Inderes Event Studio, Västra Trädgårdsgatan 19 in Stockholm, or via webcast. During the day, CEO Tom Englund, together with other members of the group management, will present the company’s strategy and financial targets. Updated financial targets will be announced in the morning of December 8.

The presentations will be held in English. Registration can be made directly via the following link: https://surgical-science-sweden.events.inderes.com/cmd-2025. For on-site participation, please register no later than December 1 via the same link.

Presentation materials and a recording of the Capital Markets Day will be made available afterwards.

Gothenburg, Sweden, October 20, 2025
Surgical Science Sweden AB (publ)

For further information, please contact:


Tom Englund, CEO
Telephone: +46-70-916 16 81
E-mail: tom.englund@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)


Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge. 

Surgical Science has approximately 330 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Seattle and Cleveland, US; and Cardiff, UK. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB. 

Attachments


Invitation to Surgical Science’s Capital Markets Day 2025

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.